BCG immunotherapy for superficial bladder cancer

This publication has 29 references indexed in Scilit:

• MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY
  Journal of Urology, 2000
• BCG Intravesical Instillations: Recommendations for Side-Effects Management
  European Urology, 2000
• The Treated Natural History of High Risk Superficial Bladder Cancer: 15-year Outcome
  Journal of Urology, 1997
• A Randomized Prospective Study Comparing Long-Term Intravesical Instillations of Mitomycin C and Bacillus Calmette-Guerin in Patients with Superficial Bladder Carcinoma
  Journal of Urology, 1996
• Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after Bacillus Calmette—Guérin (BCG) immunotherapy
  Clinical and Experimental Immunology, 1995
• Original Articles: Bladder Cancer: A Randomized Study of Intravesical Mitomycin C, Bacillus Calmette-Guerin Tice and Bacillus Calmette-Guerin RIVM Treatment in pTa-pT1 Papillary Carcinoma and Carcinoma in Situ of the Bladder
  Journal of Urology, 1995
• Analysis of early failures after intravesical instillation therapy with bacille Calmette‐Guerin for carcinoma in situ of the bladder
  British Journal of Urology, 1995
• Outcome in Carcinoma in situ of Bladder Treated with Intravesical Bacille Calmette‐Guérin
  Published by Wiley ,1992
• A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the Bladder
  New England Journal of Medicine, 1991
• ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIA
  The Lancet, 1969